Thymoma and Thymic Carcinoma

Overview

Thymoma and thymic carcinoma are tumours of the thymus, a small gland behind the breastbone in the front of the chest that plays a role in the immune system, especially in childhood. Thymoma usually grows slowly and behaves less aggressively, while thymic carcinoma is rarer and more aggressive. They are the most common tumours of the anterior mediastinum in adults.

These tumours are often linked with autoimmune conditions, particularly myasthenia gravis. Treatment centres on surgery to remove the thymus and tumour when possible, sometimes with radiotherapy or chemotherapy. Care is coordinated by a multidisciplinary team, often including thoracic surgeons and neurologists.

This page is an educational overview only and is not medical advice. Diagnosis and treatment must be arranged with a qualified thoracic oncology team, and no outcome can be guaranteed.

Who May Need This

These tumours may be found in people with symptoms such as a persistent cough, chest discomfort, breathlessness, or symptoms from pressure on nearby structures, such as difficulty swallowing or swelling of the face and neck. Many are discovered incidentally on a chest scan done for another reason.

Others are diagnosed after being investigated for myasthenia gravis or another autoimmune condition. There are no clear lifestyle risk factors, and these tumours can occur at various ages. Only a specialist can determine the diagnosis after imaging and appropriate tests.

When It May Be Recommended

Surgery is generally recommended when imaging suggests a thymic tumour that can be removed and the patient is fit for chest surgery, both to treat the tumour and to confirm the diagnosis. For tumours that are large or have grown into nearby structures, chemotherapy may be recommended first to shrink them before surgery is considered.

Radiotherapy may be recommended after surgery for higher-risk or incompletely removed tumours, or as the main treatment when surgery is not possible. The plan depends on the type, stage and completeness of removal, and is decided by the multidisciplinary team, with careful management of any associated myasthenia gravis.

Diagnosis and Evaluation

Evaluation includes CT scanning of the chest, often with MRI or PET for further detail, to assess the tumour's size and whether it involves nearby structures. Blood tests may include markers of autoimmune conditions, and testing for myasthenia gravis is important because it affects anaesthesia and management.

A tissue diagnosis may come from a needle biopsy, or the diagnosis may be confirmed by examining the tumour after surgery when it is clearly resectable. Lung and heart function are assessed for fitness for surgery. All results are reviewed by the multidisciplinary team, and a second opinion can be valuable.

Treatment Options

Surgery (thymectomy) to remove the thymus and tumour is the main treatment for resectable disease and offers the best chance of long-term control. Radiotherapy may be added after surgery for higher-risk tumours or used when surgery is not possible. Chemotherapy is used for advanced or aggressive tumours, sometimes before surgery to shrink them.

For thymic carcinoma and advanced cases, combinations of these treatments, and sometimes targeted therapy, are used. Management of associated myasthenia gravis with medicines is an important parallel part of care. The best combination depends on the type, stage and resectability, and is individualised.

How It Is Performed

Thymectomy is performed under general anaesthesia. For suitable, contained tumours, minimally invasive techniques — video-assisted thoracoscopic surgery (VATS) or robotic surgery — use small incisions and often allow faster recovery. Larger or invasive tumours are removed through an incision in the breastbone (sternotomy) to ensure complete removal, sometimes with parts of surrounding tissue.

The removed tissue is examined to confirm the type, stage and whether margins are clear, which guides any further treatment. Careful anaesthetic planning is essential in people with myasthenia gravis. Recovery is monitored in hospital, with attention to breathing and, where relevant, muscle strength.

Preparation

Preparation includes completing imaging, blood tests, and heart and lung assessment, and optimising any myasthenia gravis before surgery, as this reduces anaesthetic risk. Your team reviews medicines, especially those affecting muscle strength and blood clotting, and explains the planned approach.

If you are travelling for treatment, bring all imaging and records, including any myasthenia gravis details. Plan an in-country stay covering surgery and recovery, arrange a companion, and organise continuing follow-up — and neurological care if you have myasthenia gravis — with your home team.

Benefits and Expected Goals

The goal of treatment is complete removal of the tumour where possible, giving the best chance of long-term control, and, in people with myasthenia gravis, sometimes improvement in muscle symptoms after thymectomy. Radiotherapy and chemotherapy aim to reduce the risk of recurrence or control disease that cannot be removed.

Benefits depend on the type, stage and whether the tumour is fully removed, and cannot be guaranteed. Because these tumours can recur years later, long-term follow-up is important. Your team can explain the realistic goals for your specific tumour and situation.

Risks and Possible Complications

Chest surgery and additional treatments carry risks that the team works to minimise.

• Bleeding, infection and problems with wound or breastbone healing
• Breathing problems, especially in people with myasthenia gravis
• Injury to nearby structures such as nerves, large veins or the lining of the lung
• Radiotherapy effects in the chest, such as tiredness, and chemotherapy side effects
• Incomplete removal and the possibility of recurrence, sometimes after many years

Specialist teams take many precautions, particularly around anaesthesia in myasthenia gravis. Your team will explain the risks specific to your case. Report breathlessness, chest pain or worsening weakness urgently.

Recovery, Follow-up & Aftercare

Recovery depends on the surgical approach. Minimally invasive thymectomy often allows a shorter hospital stay and quicker return to activity, while sternotomy requires more time and care of the breastbone as it heals. Breathing exercises and gradual activity support recovery, with extra attention if myasthenia gravis is present.

Because thymic tumours can recur late, long-term follow-up with periodic scans is important. Any myasthenia gravis needs continuing neurological care. If you were treated abroad, ensure your home team has the operation and pathology details and arranges ongoing follow-up.

Medical Tourism Planning

Choose a JCI- or ISO-accredited hospital with an experienced thoracic surgery team, minimally invasive and open capability, and access to radiation and medical oncology, plus neurology support for myasthenia gravis. Confirm the surgeon's experience with thymic tumours and the planned approach in writing.

Plan an in-country stay covering surgery and recovery, request a written treatment plan and cost estimate, and arrange long-term follow-up and any neurological care with your home team. Carry your pathology report and consider medical travel insurance.

Estimated Cost Factors

Cost depends on the surgical approach (minimally invasive or open), the length of hospital stay, and whether radiotherapy or chemotherapy is needed. Imaging, pathology, anaesthesia, management of any myasthenia gravis, and treatment of complications also affect the total.

Many destinations offer thoracic cancer surgery at a fraction of typical US prices, but costs vary by case and cannot be judged from online figures. Always request a personalized written quote detailing what is included before deciding.

Choosing a Hospital or Specialist

Look for a hospital with recognised accreditation, an experienced thoracic surgery service, a multidisciplinary team, and access to radiation and medical oncology and neurology. Confirm the surgeon's experience with thymic tumours and, if you have myasthenia gravis, the availability of specialist perioperative care.

Ask about international patient services, interpreter support, and how the important long-term follow-up would be coordinated with your home doctors. Written treatment and cost plans are signs of a quality programme.

Alternatives

When surgery is not possible, alternatives include radiotherapy as the main treatment and chemotherapy for advanced or aggressive tumours, sometimes with targeted therapy. For tumours that are borderline for removal, chemotherapy may be used first to shrink them before reconsidering surgery.

Best supportive care is important in advanced disease, and clinical trials may offer newer options. Each approach has different benefits and risks. Discuss all of them with your team so the plan fits the tumour type, stage and your priorities.

Questions to Ask Your Doctor

• Is my tumour a thymoma or thymic carcinoma, and what stage is it?
• Can it be removed with surgery, and by a minimally invasive or open approach?
• Will I need radiotherapy or chemotherapy before or after surgery?
• Do I have myasthenia gravis, and how will it be managed around surgery?
• What are the specific risks in my case?
• What are the realistic goals of treatment, and how long is follow-up needed?
• If I travel, how will long-term follow-up be arranged at home?
• What is included in the written cost estimate?